Monimus Capital Management’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$902K Hold
310,908
0.66% 39
2025
Q1
$224K Hold
310,908
0.19% 47
2024
Q4
$320K Buy
+310,908
New +$320K 0.3% 48